GammaTile
GT MEDICAL TECHNOLOGIES, INC.
GammaTile radiation therapy begins working immediately at the time of brain tumor removal surgery - so there’s no waiting, no daily interruptions, and no time lost. Just the peace of mind that comes from knowing you are already moving forward. Learn more at gammatile.com
gammatile.com · Tempe, AZ
Funding event
The round itself, as filedInferred stageSeries B
Sold of offered$50.1M of $100M
Filed2026-07-22
Days since filing74
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-05-08
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- David BrachmanExecutive Officer · Director
- Per LangoeExecutive Officer · Director
- Prattipati LaxminarainExecutive Officer · Director
- Kyle DempseyDirector
- Susana AmorimDirector
- Jason RostovskyDirector
- Paul EneverDirector
- James LeechExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged50% sold4.9 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-230
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.